Bridget Butler

1.4k total citations
30 papers, 1.1k citations indexed

About

Bridget Butler is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Bridget Butler has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Bridget Butler's work include Growth Hormone and Insulin-like Growth Factors (22 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Lipid metabolism and disorders (5 papers). Bridget Butler is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (22 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Lipid metabolism and disorders (5 papers). Bridget Butler collaborates with scholars based in United States, Denmark and Canada. Bridget Butler's co-authors include Wanda Chan, Gerard J. Hickey, Roy G. Smith, Kwan Hon Cheng, Kang Cheng, Matthew J. Wyvratt, William R. Schoen, Arthur A. Patchett, Michael H. Fisher and James R. Tata and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

Bridget Butler

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bridget Butler United States 15 536 477 279 270 215 30 1.1k
Akira Gomori Japan 17 134 0.3× 498 1.0× 308 1.1× 233 0.9× 274 1.3× 25 1.1k
Beth Murphy United States 13 107 0.2× 314 0.7× 340 1.2× 300 1.1× 186 0.9× 25 830
Kazuhiro Momose Japan 13 193 0.4× 176 0.4× 447 1.6× 139 0.5× 79 0.4× 26 877
Sam R.J. Hoare United States 25 197 0.4× 236 0.5× 721 2.6× 139 0.5× 174 0.8× 44 1.3k
Nicholas D. Holliday United Kingdom 21 137 0.3× 377 0.8× 925 3.3× 220 0.8× 347 1.6× 56 1.5k
Jun‐ichi Eiki Japan 17 423 0.8× 230 0.5× 791 2.8× 227 0.8× 89 0.4× 28 1.3k
David R. Luthin United States 15 89 0.2× 68 0.1× 352 1.3× 136 0.5× 39 0.2× 26 703
Joseph W. Gunnet United States 19 133 0.2× 131 0.3× 277 1.0× 55 0.2× 24 0.1× 43 974
Michael E. Brune United States 18 155 0.3× 113 0.2× 251 0.9× 80 0.3× 74 0.3× 41 746
Blair Weig United States 14 25 0.0× 241 0.5× 320 1.1× 115 0.4× 200 0.9× 20 711

Countries citing papers authored by Bridget Butler

Since Specialization
Citations

This map shows the geographic impact of Bridget Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Butler more than expected).

Fields of papers citing papers by Bridget Butler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Butler. The network helps show where Bridget Butler may publish in the future.

Co-authorship network of co-authors of Bridget Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget Butler. A scholar is included among the top collaborators of Bridget Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget Butler. Bridget Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butler, Bridget, et al.. (2018). La science citoyenne au service de la conservation : deux programmes dans la région transfrontalière des montagnes Vertes dans la chaîne des Appalaches. Érudit (Université de Montréal). 143(1). 118–125. 1 indexed citations
2.
Butler, Bridget, et al.. (2014). Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice.. PubMed. 2(2). 18 indexed citations
3.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2007). Highly potent growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(13). 3657–3659. 8 indexed citations
4.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2003). Substituted bridged phenyl piperidines: orally active growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 13(10). 1817–1820. 5 indexed citations
5.
Ashton, Wallace T., Yi Yang, Joel B. Yudkovitz, et al.. (2001). Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus. Bioorganic & Medicinal Chemistry Letters. 11(13). 1727–1731. 31 indexed citations
6.
Chen, Meng‐Hsin, Arthur A. Patchett, Kang Cheng, et al.. (1999). Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 9(9). 1261–1266. 28 indexed citations
8.
Tata, James R., Ravi P. Nargund, David B. Johnston, et al.. (1997). The synthesis and activity of spiroindane growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 7(6). 663–668. 10 indexed citations
9.
Ok, Hyun, G. A. Doldouras, William R. Schoen, et al.. (1996). Benzolactam growth hormone secretagogues: Replacement of the C-3 amide bond in L-692,429. Bioorganic & Medicinal Chemistry Letters. 6(24). 3051–3056. 8 indexed citations
10.
DeVita, Robert J., William R. Schoen, G. A. Doldouras, et al.. (1995). Heterocyclic analogs of the benzolactam nucleus of the non-peptidic growth hormone secretagogue L-692,429. Bioorganic & Medicinal Chemistry Letters. 5(12). 1281–1286. 9 indexed citations
11.
Patchett, Arthur A., Ravi P. Nargund, James R. Tata, et al.. (1995). Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.. Proceedings of the National Academy of Sciences. 92(15). 7001–7005. 268 indexed citations
12.
Chu, Lin, Helmut Mrozik, Michael H. Fisher, et al.. (1995). Aliphatic replacements of the biphenyl moiety of the nonpeptidyl growth hormone secretagogues L-692,429 and L-692,585. Bioorganic & Medicinal Chemistry Letters. 5(19). 2245–2250. 7 indexed citations
13.
Schoen, William R., Robert J. DeVita, Judith M. Pisano, et al.. (1994). Structure-activity relationships in the amino acid sidechain of L-692,429. Bioorganic & Medicinal Chemistry Letters. 4(9). 1117–1122. 28 indexed citations
14.
Cheng, Kang, et al.. (1993). A Novel Non-Peptidyl Growth Hormone Secretagogue. Hormone Research. 40(1-3). 109–115. 47 indexed citations
15.
Smith, Roy G., Kang Cheng, William R. Schoen, et al.. (1993). A Nonpeptidyl Growth Hormone Secretagogue. Science. 260(5114). 1640–1643. 271 indexed citations
16.
Chan, Wanda, et al.. (1993). Pituitary Adenylate Cyclase Activating Polypeptide-Induced Desensitization on Growth Hormone Release from Rat Primary Pituitary Cells. Biochemical and Biophysical Research Communications. 197(3). 1396–1401. 22 indexed citations
17.
Cheng, Kwan Hon, Wanda Chan, Bridget Butler, et al.. (1993). Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.. Endocrinology. 132(6). 2729–2731. 60 indexed citations
18.
Chan, Wanda, et al.. (1992). PMA-sensitive protein kinase C is not necessary in TRH-stimulated prolactin release from female rat primary pituitary cells. Life Sciences. 51(25). 1957–1967. 6 indexed citations
20.
Søgaard, Ulf, et al.. (1990). A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects. International Clinical Psychopharmacology. 5(4). 237–252. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026